ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EVOQ Announces License, Collaboration Agreement with Amgen americanpharmaceuticalreview
January 21, 2021?EVOQ Therapeutics announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders. -
EVOQ Therapeutics and Amgen Partner contractpharma
January 14, 2021?EVOQ Therapeutics has signed a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders. -
Sanofi to acquire Synthorx for $2.5 B biospectrumasia
December 12, 2019Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.
Pharma Sources Insight January 2025
